Literature DB >> 19247617

Solid phase assays for studying ECM protein-protein interactions.

Paul A Mould1.   

Abstract

Solid-phase assays provide a simple, rapid and robust method for the analysis of protein-protein interactions; i.e., does protein A interacts with protein B? In this assay, protein A (here termed as 'receptor') is adsorbed to the wells of an enzyme-linked immunosorbent assay (ELISA) plate (solid phase). The plate is then blocked using bovine serum albumin (BSA), and biotin-labelled protein B (here termed as 'ligand') is added. After washing the wells to remove unbound ligand, bound ligand is detected by addition of an avidin-peroxidase conjugate followed by a colorimetric detection step. This type of assay is particularly well suited for studying the interaction of ECM proteins with integrins. The screening of antagonists of integrin-ligand interactions in the pharmaceutical industry is an important area in which this assay is finding use.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19247617     DOI: 10.1007/978-1-59745-413-1_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain.

Authors:  Tamara Rosell-García; Alberto Paradela; Gema Bravo; Laura Dupont; Mourad Bekhouche; Alain Colige; Fernando Rodriguez-Pascual
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

2.  Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPF.

Authors:  Martin L Decaris; Johanna R Schaub; Chun Chen; Jacob Cha; Gail G Lee; Megi Rexhepaj; Steve S Ho; Vikram Rao; Megan M Marlow; Prerna Kotak; Erine H Budi; Lisa Hooi; Jianfeng Wu; Marina Fridlib; Shamra P Martin; Shaoyi Huang; Ming Chen; Manuel Muñoz; Timothy F Hom; Paul J Wolters; Tushar J Desai; Fernando Rock; Katerina Leftheris; David J Morgans; Eve-Irene Lepist; Patrick Andre; Eric A Lefebvre; Scott M Turner
Journal:  Respir Res       Date:  2021-10-19

3.  LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention.

Authors:  P Stampolidis; A Ullrich; S Iacobelli
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.